On July 30th, Merck announced its first half of 2024 results, with a total revenue of 31.887 billion US dollars, a year-on-year increase of 8%. Merck's pharmaceutical business revenue was 28.415 billion US dollars, a year-on-year increase of 9%. Among them, the China region achieved a revenue of 3.534 billion US dollars, accounting for 12.4% of Merck's global market share. The R&D investment was 7.492 billion US dollars, a year-on-year decrease of 57%.
Reviewing ...
阅读全文